Hajar Fakhor
Research Subjects
Research Interests
Hajar Fakhor has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Gulzar Mbbs Ahmed
Dow Medical College
1 shared publication - Harmandeep K. Sidhu
Dayanand Medical College and Hospital, Ludhiana, India
1 shared publication - Komal Mbbs Kumari
Ziauddin Medical University, Karachi
1 shared publication - Koushik Mbbs Majumder
Chittagong Medical College, Chittagong, Bangladesh
1 shared publication - Momil Mbbs Muzaffar
CMH Lahore Medical College, Lahore, Pakistan
1 shared publication - Muhammad Hassaan Mbbs Wajid
Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
1 shared publication
Latest Publications
- Open Access
- 4 December 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (2) , 909-919
Paroxysmal atrial fibrillation and hemochromatosis: a narrative review
Paroxysmal atrial fibrillation (PAF) and hemochromatosis have a complex relationship. This review explores its mechanisms, prevalence, correlations, and clinical manifestations. Hereditary hemochromatosis (HH) involves iron overload due to HFE protein mutations, while atrial fibrillation (AF) is characterized by irregular heart rhythms. Iron overload in hemochromatosis can promote cardiac arrhythmias. AF is prevalent in developed countries and may be linked to cryptogenic strokes. Genetic variations and demographic factors influence the occurrence of both conditions. HH affects multiple organ systems, including the heart, while AF causes palpitations and reduced exercise tolerance. Diagnosis involves iron markers, genotypic testing, and electrocardiogram (ECG) findings. Treatment strategies focus on reducing iron levels in hemochromatosis and managing AF through antithrombotic therapy and rhythm control. Untreated hemochromatosis carries a higher risk of complications, and PAF is associated with increased cardiovascular-related mortality. For better understanding of the mechanisms and to improve management, additional studies are required. Tailored approaches and combined treatments may enhance patient outcomes.
- 4 December 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (2) , 909-919
Open AccessParoxysmal atrial fibrillation and hemochromatosis: a narrative review
Paroxysmal atrial fibrillation (PAF) and hemochromatosis have a complex relationship. This review explores its mechanisms, prevalence, correlations, and clinical manifestations. Hereditary hemochromatosis (HH) involves iron overload due to HFE protein mutations, while atrial fibrillation (AF) is characterized by irregular heart rhythms. Iron overload in hemochromatosis can promote cardiac arrhythmias. AF is prevalent in developed countries and may be linked to cryptogenic strokes. Genetic variations and demographic factors influence the occurrence of both conditions. HH affects multiple organ systems, including the heart, while AF causes palpitations and reduced exercise tolerance. Diagnosis involves iron markers, genotypic testing, and electrocardiogram (ECG) findings. Treatment strategies focus on reducing iron levels in hemochromatosis and managing AF through antithrombotic therapy and rhythm control. Untreated hemochromatosis carries a higher risk of complications, and PAF is associated with increased cardiovascular-related mortality. For better understanding of the mechanisms and to improve management, additional studies are required. Tailored approaches and combined treatments may enhance patient outcomes.